Brainstorm Cell Therapeutics Inc. BCLI
Set alert
0.85 USD +0.02 +2.94%
As of Nov 3, 10:02 AM ET
0.85 Day range 0.85
0.46 52-week range 1.69
- YTD
- +54.55%
- 1 year
- +30.77%
- Open
- 0.85
- Prev close
- 0.8257
- Mkt cap
- 9.38M
- Vol
- 6.45K
- Avg vol
- 21.79K
- EPS
- -0.93
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.85
- High
- 0.85
- Forward P/E
- -0.91
- Beta
- 0.39
- Short ratio
- 1.25
- Inst. own
- 13.90%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.70
- 200-d avg
- 4.88
- 1y target
- 23.45
MAX chart
Events in this range
- Feb 5, 2021Rating: Maxim Group · Hold → Buy
- Apr 1, 2024Earnings: -1.65; estimate -2.25; surprise 26.67%
- Oct 1, 2024Split: 1 for 15
Signals (107)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Mar 1, 2026 | 8 months ago |
| SMA: Bearish | Jul 1, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 1, 2024 | 2 years ago |
| SMA: Bullish | May 1, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 1, 2023 | 3 years ago |
| SMA: Bearish | Jun 1, 2023 | 3 years ago |
| SMA: Bullish | Mar 1, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 1, 2023 | 3 years ago |
| SMA: Bearish | Nov 1, 2022 | 4 years ago |
| MACD: Sell Signal | Nov 1, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 1, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bearish | Jan 1, 2022 | 4 years ago |
| SMA: Bullish | Nov 1, 2021 | 5 years ago |
| SMA: Bearish | Feb 1, 2021 | 5 years ago |
| SMA: Bullish | Jan 1, 2021 | 5 years ago |
| MACD: Sell Signal | Dec 1, 2020 | 5 years ago |
| SMA: Bearish | Nov 1, 2020 | 6 years ago |
Newest 20 of 107.
Analyst view
Consensus: buy
Buy
Price target (mean) 23.45 +2658.8% upside
Now 0.85
- Target (low)
- 10.00
- Target (mean)
- 23.45
- Target (high)
- 36.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.27 | -0.27 – -0.27 | -1.50 | +82.0% | 0 | 0.0% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -2.10 | -2.10 – -2.10 | -7.62 | +72.4% | 0 | 0.0% | 1 |
| Next year | -1.59 | -1.65 – -1.52 | -2.10 | +24.5% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 11, 2024 | Maxim Group | Upgrade | Hold | Buy |
| Sep 28, 2023 | Maxim Group | Downgrade | Buy | Hold |
| Mar 31, 2023 | Maxim Group | Maintained | — | Buy |
| Feb 5, 2021 | Maxim Group | Upgrade | Hold | Buy |
| May 15, 2018 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 17, 2017 | Maxim Group | Maintained | — | Buy |